Adicet Bio
The Director / Sr. Director of Program Management at Adicet Bio will lead cross‑functional project teams to plan, coordinate, and track integrated implementation plans aligned with product development and budget goals. This role oversees timelines, risk management, resource allocation, and communication with stakeholders, ensuring program milestones are met and supporting the company's gamma delta T‑cell therapy pipeline.
Adicet Bio is a clinical-stage biotechnology company developing off-the-shelf, allogeneic gamma delta T cell therapies for cancer and autoimmune diseases. Their proprietary platform engineers Gamma Delta 1 CAR T cells to enable novel targeting, tissue homing, and improved drug exposure with the goal of delivering best-in-class, on‑demand cell therapies. Adicet advances a pipeline of engineered cell therapy candidates and provides regular clinical and investor updates from offices in Redwood City, Boston and Shanghai.
Press Release Service: Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
Nov 6, 2025
Adicet Bio (ACET) Projected to Post Quarterly Earnings on Thursday
1 week ago
Woodline takes 6.5% passive stake in Adicet Bio (ACET)
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Adicet Bio.
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
Oct 7, 2025
Executive Director, Global Product Leader (GPL – Solid Tumor Franchise)
AstraZeneca
Associate Director, Project Management
Sana Biotechnology
Director of Scientific Marketing, Melanoma
Iovance Biotherapeutics
Director, Clinical Science
Lyell Immunopharma
Senior Director, Immuno-Oncology
AstraZeneca
Executive Director, Global Program Leader
Legend Biotech